US Stem Cell Inc (USRM)

[Carl Spackler]

Imagine USRM opening a Dallas office and successfully treating a few dozen patients. What "additional information" could the FDA possibly request at that point? How would they be able to justify anything other than a full RMAT designation? Of course, we may have an answer from them well before all that happens. Although I still do not trust Tomas one bit, it does seem to me that he made a very good gamesmanship decision here: FDA, take your damn time. If you grant RMAT, great (but we're not spending any more money pursuing it). If you don't grant it, no problem. You'll eventually be forced to do so by virtue of our results and by public demand instigated in TX.